Latest Revenue Growth News

Web Travel Group (ASX:WEB) reported a standout FY26, driven by its WebBeds B2B platform’s 20% TTV growth and 24% EBITDA increase, while redeeming $250 million convertible notes and releasing its inaugural climate-focused Sustainability Report.

PaySauce has successfully launched its Global Payroll Platform in Australia, targeting nearly 700,000 micro-businesses, supported by a $5 million capital raise and steady growth in its New Zealand operations.

CleanSpace Holdings expects modest revenue growth for FY26, hindered by product certification delays and global market challenges, while maintaining a strong cash position and preparing a new respirator launch.

Millennium & Copthorne Hotels New Zealand (MCK) posted robust 2025 revenue gains driven by acquisitions and refurbishments, yet signals a cautious outlook for 2026 as geopolitical tensions and rising costs cloud the horizon.

Adveritas Limited’s annualised recurring revenue (ARR) has surged to $16.3 million, driven by rapid organic growth of its SME self-serve platform and expanding North American footprint beyond gaming.

Fredon, the electrical and mechanical arm of NRW Holdings (ASX:NWH), has secured $120 million in new contracts across Victoria and Western Australia, reinforcing its role in critical infrastructure projects.

Osteopore has secured Hainan FDA approval to clinically use and sell its custom orthopaedic devices at Shanghai Ruijin Hospital’s Hainan branch, marking a key step towards wider China market access. The company has scheduled its first patient surgery for June 2026.

Aroa Biosurgery posted a breakout FY26, beating revenue and EBITDA guidance with a 54% surge in Myriad sales. The company plans significant investments in FY27 to accelerate growth and capitalise on new market opportunities.

Viva Leisure has lifted its FY26 net profit after tax guidance by more than 130%, driven by strong margins and a booming technology segment, while reaffirming revenue and EBITDA targets.

New Zealand King Salmon (NZK) reversed prior losses with a $13.8 million net profit in 1HY26, upgrading its full-year earnings outlook and advancing key growth infrastructure.

Fisher & Paykel Healthcare posted a 14% revenue increase to NZ$2.31 billion and a 24% rise in net profit to NZ$468.5 million for FY2026, driven by strong hospital product sales and ongoing innovation.

Little Green Pharma has secured Federal Court approval for its full acquisition of Cannatrek, marking a key milestone in expanding its global medicinal cannabis footprint. The scheme became effective on 25 May 2026, with implementation set for 1 June.